Get a reply from this employer — a resume and cover letter tailored to exactly what they’re hiring for.
Vaxxinova US is seeking an Associate Manufacturing Technician to join our Small Autogenous Lab in Willmar, MN. This role involves manufacturing vaccines using proprietary SRP technology and supporting production, process improvement, and delivery to customers.
Shift: Monday–Friday 7:30am–4:00pm. The ideal candidate will have a high school diploma, 1–2 years manufacturing experience, and the ability to lift up to 50 lbs; training provided on sterile practices and safety.
If you are unable to complete this application due to a disability, contact this employer to ask for an accommodation or an alternative application process.
Full Time Willmar, MN, US
Salary Range: $20.00 To $26.00 Hourly
Vaxxinova US is seeking an Associate Manufacturing Technician to join our Small Autogenous Lab team in Willmar, MN.
About the role:As a key member of the small autogenous (custom) lab, the Production Technician is responsible for all aspects of manufacturing vaccine using proprietary SRP technology. This critical role will be engaged in production, process improvement, and the support functions necessary to ensure vaccine delivery to customers.
Shift: Monday through Friday 7:30am to 4:00pm
Main responsibilities:
Qualifications and Capabilities
Education and Experience
Benefits at Vaxxinova:
We are proud to offer a generous benefit package in addition to competitive compensation, including employer contributions towards medical, dental and vision premiums. Most benefits begin on date of hire. Our benefits include:
About Vaxxinova
Vaxxinova provides a wide range of both autogenous and licensed vaccines combined with high-level diagnostic services, supported by strong R&D. Our focus is on livestock including cattle, poultry, swine and aqua. Vaxxinova US, formerly known as Epitopix and Newport Laboratories, is the US operating unit of Vaxxinova International, headquartered in the Netherlands. Vaxxinova US has a strong market presence making autogenous vaccines for cattle, swine, and poultry as well as a state-of-the‑art diagnostic laboratory. Vaxxinova currently has facilities in fourteen countries including Brazil, Canada, Chile, Colombia, Croatia, Italy, Germany, Japan, Jordan, Norway, South Africa, Thailand, the USA, and the Netherlands. Vaxxinova is part of the family‑owned EW Group, headquartered in Germany. The EW Group specializes in animal genetics, animal nutrition and animal health, operates in over 100 countries and records consistent international growth.